Courtney Arn, APRN-CNP, a nurse practitioner comments on the recent approval of pembrolizumab for patients with MSI-H/dMMR advanced endometrial carcinoma.
Courtney Arn, APRN-CNP
Advertisement
Articles by Courtney Arn, APRN-CNP
Advertisement
Latest Updated Articles
Nurse Takeaways: Latest Pembrolizumab Indication in Endometrial CancerPublished: April 10th 2022 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
2
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
3
NGS Streamlines Biomarker Testing in Solid Tumors
4
Osimertinib/Chemo Boosts OS in EGFR+ NSCLC With Poor Prognosis
5
